Publications by authors named "Seza A Gulec"

Claim this Profile
T
Thyroid differentiation profile for differentiated thyroid cancer.
Anthony J McGoron, Jose M Garcia, Burulça Uluvar, Seza A Gulec

Endocr Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Consequences of Thyroidectomy and Patient-Centered Management.
Karina Wang, Seza A Gulec

J Clin Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Perspectives in Radioactive Iodine Theranostics: Current Redifferentiation Protocols for Mis-Differentiated Thyroid Cancer.
Seza A Gulec, Cristina Benites, Maria E Cabanillas

J Clin Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theranostic Risk Stratification for Thyroid Cancer in the Genomic Paradigm.
Seza A Gulec, Evander Meneses

Cancers (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management.
Simion Chiosea, Steven P Hodak, Linwah Yip, Devaprabu Abraham, Chelsey Baldwin, Seza A Gulec

J Clin Endocrinol Metab· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Birth of the Beta-knife Thyroidectomy: The Radiance of Saul Hertz.
John D Ehrhardt, Seza A Gulec

Am Surg· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroidectomy without Radioiodine in Low-Risk Thyroid Cancer.
Seza A Gulec, Anthony J McGoron

N Engl J Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomicrosphere Dosimetry: Principles and Current State of the Art.
Seza A Gulec, Anthony J McGoron

Semin Nucl Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on Current Diagnostic and Theranostic Approaches in the Management of Thyroid Cancer.
Seza A Gulec, Sukhjeet Ahuja, Anca M Avram, Victor J Bernet, Patrick Bourguet

Thyroid· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Papillary Thyroid Carcinoma and Kostmann Syndrome: A Genomic Theranostic Approach for Comprehensive Treatment.
Soo Han, John Ehrhardt, Savya Shukla, Adel Elkbuli, Yuri E Nikiforov, Seza A Gulec

Am J Case Rep· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y SPECT/CT quantitative study and comparison of uptake with pretreatment Tc-MAA SPECT/CT in radiomicrosphere therapy.
Senait Aknaw Debebe, Malek Adjouadi, Seza A Gulec, Juan Franquiz, Anthony J McGoron

J Appl Clin Med Phys· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(124)I PET/CT in Patients with Differentiated Thyroid Cancer: Clinical and Quantitative Image Analysis.
Seza A Gulec, Russ A Kuker, Mohammed Goryawala, Carlos Fernandez, Rudolfo Perez

Thyroid· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Y-90 Radiomicrosphere Therapy for Colorectal Cancer Liver Metastases.
Seza A Gulec

Semin Nucl Med· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-FLT Positron Emission Tomography/Computed Tomography Imaging in Pancreatic Cancer: Determination of Tumor Proliferative Activity and Comparison with Glycolytic Activity as Measured by 18F-FDG Positron Emission Tomography/Computed Tomography Imaging.
Senait Aknaw Debebe, Mohammed Goryawala, Malek Adjouadi, Anthony J Mcgoron, Seza A Güleç

Mol Imaging Radionucl Ther· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-pigmented melanoma with nodal metastases masquerading as pyogenic granuloma in a 1-year old.
Jun Tashiro, Chad A Perlyn, Steven J Melnick, Seza A Gulec, Cathy A Burnweit

J Pediatr Surg· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial.
Seza A Gulec, Kenneth Pennington, James Wheeler, Tushar C Barot, Rekha R Suthar

Am J Clin Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial.
Allyson J Ocean, Kenneth L Pennington, Michael J Guarino, Arif Sheikh, Tanios Bekaii-Saab, Seza A Gulec

Cancer· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An algorithm for PET tumor volume and activity quantification: without specifying camera's point spread function (PSF).
Ruchir Bhatt, Malek Adjouadi, Mohammed Goryawala, Seza A Gulec, Anthony J McGoron

Med Phys· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of functional tumor volume and total lesion glycolysis in patients with colorectal cancer liver metastases undergoing 90Y selective internal radiation therapy plus chemotherapy.
Seza A Gulec, Rekha R Suthar, Tushar C Barot, Kenneth Pennington

Eur J Nucl Med Mol Imaging· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of advanced pancreatic carcinoma with 90Y-Clivatuzumab Tetraxetan: a phase I single-dose escalation trial.
Seza A Gulec, Steven J Cohen, Kenneth L Pennington, Lionel S Zuckier, Ralph J Hauke

Clin Cancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy.
Seza A Gulec, Manuel L Sztejnberg, Jeffry A Siegel, Tatjana Jevremovic, Michael Stabin

J Nucl Med· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological factors, tumor growth kinetics, and survival after metastasectomy for pulmonary melanoma.
Jonathan H Lee, Seza A Gulec, Ainura Kyshtoobayeva, Myung-Shin Sim, Donald L Morton

Ann Surg Oncol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2009 EANM parathyroid guidelines.
Elif Hindié, Omer Ugur, David Fuster, Michael O'Doherty, Gaia Grassetto, Seza A Gulec

Eur J Nucl Med Mol Imaging· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections.
Seza A Gulec, Kenneth Pennington, Michael Hall, Yuman Fong

World J Surg Oncol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttherapy radiation safety considerations in radiomicrosphere treatment with 90Y-microspheres.
Seza A Gulec, Jeffry A Siegel

J Nucl Med· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis